Bibliometric analysis on research of etimicin from 1997 to 2017
XIE Fa-hong
ZHANG Xin-jian
LI De-dong
CHAI Dong
Abstract：Objective: To analyze the literature related to the clinical research of etimicin at the time of etimicin listed in China for 20 years, so as to provide references for clinical rational drug use. Methods: Based on the methods of bibliometrics, the relevant literature on the clinical research of etimicin were collected and summarized. Statistical analysis was carried out in terms of the publication date, languages, journals, types of literature, types of clinical infection, adverse reactions and incompatibility. Results: A total of 527 literature were included. The domestic research was dominant among the related literature, most of which were published in Chinese journals (374 journals, 98.9%). Clinical research of etimicin mainly focused on respiratory infection (86 studies, 57.7%). ADR research of etimicin mainly focused on ototoxicity and nephrotoxicity (38 studies, 52.1%), and the incompatibility of etimicin with cephalosporins was reported in 38 articles, which accounted for 40.4% among enrolled studies. Conclusion: As a self-developed aminoglycoside antibiotic in China, etimicin had a wide range of clinical applications and a lower incidence of adverse reactions than similar varieties. It is of great significance to further study and explore etimicin for the prevention and treatment of infectious diseases.
Keywords：EtimicinClinical applicationBibliometric analysis
Publication Date：2018-01-01
Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)
Pages：4( 303-306 )